Indacaterol/glycopyrronium

DRUG2 trials

Sponsors

Taipei Medical University Shuang Ho Hospital, Orion Corporation, Orion Pharma

Conditions

Chronic Obstructive Pulmonary DiseaseHealthy Volunteers

Phase 1

Study to Compare Relative Bioavailability of 3 Indacaterol/Glycopyrronium Test Products and Reference Product

CompletedNCT05288075

Orion Corporation, Orion PharmaHealthy Volunteers

Start: 2022-02-28End: 2022-06-27Updated: 2022-07-13

Phase 4

Utilizing Wearable Device to Observe the Clinical Response of COPD Patients Treated With Combined Bronchodilator and Home-based Pulmonary Rehabilitation Program

Taipei Medical University Shuang Ho HospitalChronic Obstructive Pulmonary Disease

Start: 2016-01-01End: 2018-06-30Target: 50Updated: 2018-04-30